Tyra Biosciences, Inc. TYRA EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s EPS (diluted)?
- Tyra Biosciences, Inc. (TYRA) reported EPS (diluted) of -$0.64 in Q1 2026.
- How has Tyra Biosciences, Inc.'s EPS (diluted) changed year-over-year?
- Tyra Biosciences, Inc.'s EPS (diluted) decreased by 36.2% year-over-year, from -$0.47 to -$0.64.
- What is the long-term trend for Tyra Biosciences, Inc.'s EPS (diluted)?
- Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s EPS (diluted) has grown at a 14.9% compound annual growth rate (CAGR), from -$1.32 to -$2.00.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.